Back
Nektar Therapeutics Stock Predictions
The Next AI Breakouts Won't Talk Like ChatGPT
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
38
NKTR
Nektar Therapeutics
Last Price:
$36.79
Seasonality Move:
1.26%
7 Day Trial
ALL ACCESS PASS
$
7
This Critical Mineral's Up 122% in the Last 12 Months.
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atNektar Therapeutics Stock Forecast
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 30.4% based on the past 31 years of stock performance.
-
Nektar Therapeutics has risen higher in 16 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.61%
-
Is Nektar Therapeutics Stock Undervalued?The current Nektar Therapeutics [NKTR] share price is $36.81. The Score for NKTR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Nektar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 30.4% based on the past 31 years of stock performance.
Nektar Therapeutics Stock Rating
Sell
38
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics overpriced?
-
Nektar Therapeutics has risen higher in 16 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.61%
Nektar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com
52-Week Data
52-Week High:
66.92
52-Week Low:
6.48
Prediction Charts
Market Cap:
636.8M
Price in USD:
36.81
Volume:
416.6K
Beta:
1.26
Technical Analysis
SMA50:
45.46
SMA100:
51.68
SMA200:
35.94
52-Wk Change:
250.07%
Stock Predictions
-
Is Nektar Therapeutics stock public?Yes, Nektar Therapeutics is a publicly traded company.
-
What is the Nektar Therapeutics stock quote today?The Nektar Therapeutics stock price is 36.81 USD today.
-
How to buy Nektar Therapeutics stock online?You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 36.10 | 36.23 | 36.77 | 35.03 |
| Jan-21 | 36.07 | 36.92 | 36.99 | 35.08 |
| Jan-22 | 36.92 | 36.53 | 37.99 | 35.77 |
| Jan-23 | 37.82 | 37.11 | 39.75 | 36.72 |
| Jan-26 | 36.77 | 37.18 | 37.50 | 35.95 |
| Jan-27 | 37.40 | 38.03 | 38.36 | 36.82 |
| Jan-28 | 37.78 | 35.91 | 38.40 | 35.82 |
| Jan-29 | 35.65 | 35.23 | 36.20 | 34.82 |
| Jan-30 | 35.02 | 37.33 | 37.70 | 33.40 |
| Feb-2 | 37.29 | 38.12 | 39.43 | 37.05 |
| Feb-3 | 38.06 | 38.86 | 39.13 | 37.64 |
| Feb-4 | 38.44 | 37.64 | 38.93 | 36.13 |
| Feb-5 | 37.60 | 35.12 | 38.47 | 34.90 |
| Feb-6 | 35.18 | 36.81 | 37.26 | 34.47 |
Nektar Therapeutics Earnings
Nektar Therapeutics Earnings Report: Per Share Nektar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Nektar Therapeutics Forecast Revenue Growth
Nektar Therapeutics Stock Analysis: Historical quarterly revenues per share for Nektar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.54 per share, and a decrease next year of $2.39 per share.
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.